The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of ailments involving the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study included about 800 elderly men with low testosterone and symptoms related to this affliction, including http://tinyurl.com/dy2gf6h
sexual and physical dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.
Research has shown that testosterone deficiency is related to a number of important health problems including metabolic
syndrome, obesity, diabetes, and bone fractures Guys who meet medical criteria for treatment
should receive therapy. In fact, your testosterone levels have likely been slowly declining for quite some time, a decline that usually begins around age 30.
No clear lower limit of testosterone has been confirmed; nonetheless 15 ng per dL (0.5 nmol per L) commonly is used. One study 38 found that girls with 0 to 10 ng per dL (0 to 0.3 nmol per L) had markedly decreased sexual desire in all situations and absent or markedly reduced climaxes. As a result of studies such as this, supplemented with anecdotal evidence, many girls have been started on testosterone treatment. Most women can expect to spend one third of their lives in the postmenopausal period. Depression, anger, moodiness, insomnia, and lack of well-being are common criticisms of postmenopausal women.